A randomised phase III study of single fraction radiotherapy compared to multifraction radiotherapy in patients with metastatic spinal cord compression
Radiation therapy uses high-energy x-rays to kill tumor cells. It is not yet known which radiation therapy regimen is more effective in treating metastatic spinal cord compression. This randomised clinical trial is comparing two radiation therapy regimens to see how well they work in treating patients with metastatic spinal cord compression.
Primary Sponsor
University College London (UCL)
Collaborating Groups
Trans Tasman Radiation Oncology Group (TROG)
Participating Centres
Final Accrual
694
Current Accrual
Trial Chairperson
Dr Tanya Holt
Trial Contact
Kacy.Baumann@health.qld.gov.au
Related Post
February 28, 2022
Cancer trial participant hoping to help
The RAVES trial treating prostate cancer Participating in a
June 15, 2021
Individualising radiotherapy for women with DCIS of the breast reduces recurrence after surgery
Ductal carcinoma in situ (DCIS) of the breast is
